570403-14-4 Usage
Description
4-Piperidinecarboxylic acid, 1-[3-chloro-5-[[[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]amino]carbonyl]-2-pyridinyl]-, ethyl ester is a complex organic compound with potential applications in the pharmaceutical industry. It is a derivative of piperidinecarboxylic acid, featuring a chloropyridinyl and thiazolyl moiety, which may contribute to its biological activity.
Used in Pharmaceutical Industry:
4-Piperidinecarboxylic acid, 1-[3-chloro-5-[[[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]amino]carbonyl]-2-pyridinyl]-, ethyl ester is used as a potential drug candidate for the treatment of certain diseases and conditions. Its potential anti-inflammatory and analgesic properties, along with possible effects on the central nervous system, make it a promising candidate for further research and development.
Used in Research and Development:
4-Piperidinecarboxylic acid, 1-[3-chloro-5-[[[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]amino]carbonyl]-2-pyridinyl]-, ethyl ester is used as a subject of study in research and development for understanding its pharmacological effects and potential medical applications. Further investigation is required to fully comprehend its therapeutic potential and optimize its use in the medical field.
Check Digit Verification of cas no
The CAS Registry Mumber 570403-14-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,7,0,4,0 and 3 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 570403-14:
(8*5)+(7*7)+(6*0)+(5*4)+(4*0)+(3*3)+(2*1)+(1*4)=124
124 % 10 = 4
So 570403-14-4 is a valid CAS Registry Number.
570403-14-4Relevant articles and documents
Preparation method of thrombocyte increasing agent
-
, (2018/03/01)
The invention relates to a preparation method of a thrombocyte increasing agent. The preparation method comprises the following steps: enabling a midbody 1 and a midbody 2 to perform amidation in the presence of a catalyst in an aprotic solvent; and adding alkali into a solvent of a midbody A to perform the alkaline hydrolysis reaction to obtain a target compound. The midbody 2 is firstly synthesized and then reacts with the midbody 1; and a synthetic route of the method is a converging reaction, so that the yield is increased, and convenience in quality control is achieved. In addition, by studying the reaction amplification feasibility, the operation such as column chromatography is avoided, the method is more suitable for an industrialized production process, and the emission of waste liquid is reduced. A product obtained by the route is high in purity, the yield is high, the pollution is small, and the preparation method is suitable for the industrialized production.